ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib

Leilei Niu(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong)
Cell Death and Disease
August 28, 2018
Cited by 26


Related Papers